Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flovent for Pediatric Vocal Fold Nodules
NCT03040596Phase 1Terminated
- Start
- Mar 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fluticasone propionate in Vocal fold nodules. Primary endpoints: Adverse Events at 1 year and Compliance with inhaler use at 4 weeks. Started Mar 2017; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
Vocal fold nodules
Beyond the preview
Go deeper on NCT03040596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040596.